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INTRODUCTION
Pre-labour premature rupture of membranes (PPROM) is deﬁned as rupture of
membranes more than 1 hour prior to the onset of labour at <37 weeks gestation.
PPROM occurs in approximately 3% of pregnancies and is responsible for a third of
all preterm births.1 Once membranes are ruptured prolonging the pregnancy has no
maternal physical advantage but fetal morbidity and mortality are improved daily at
early gestations: 19% of those infants born <25 weeks develop cerebral palsy (CP)
and 28% have severe motor disability.2 Those infants born extremely pre term (<28
weeks) cost the public sector £75835 (95% CI £27906–145508) per live birth3 not
to mention the emotional cost to the family. To prolong gestation is therefore the
suggested goal: however how and why might we delay birth in those at risk?
PPROM is one scenario associated with preterm birth and here we discuss the
causative mechanisms, sequelae, latency, strategies to prolong gestation (antibiotics)
and consider the role of amniocentesis. We will also discuss novel therapies.
PATHOPHYSIOLOGY OF MEMBRANE RUPTURE
Themembranes,whichacttoprotectandisolatethefetus,arecomposedoftwolayers.
The inner layer (amnion) which connects after fusion in the late ﬁrst trimester, to the
outer layer (chorion leave) through a collagen-rich vascular zone. These membranes
are directly apposed to the maternal decidua.
The high resilience of the preterm fetal membranes makes them strong enough
to withstand strong non-penetrating forces.4 The supra-cervical portion of the
membranes has been proposed as the site where the process of weakening and rupture
through collagen remodelling5 may be initiated.6 Collagen remodelling is executed
through the activation of the collagen speciﬁc matrix metalloproteinases (MMPs)
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in the extracellular matrix of the amniochorionic membrane. This remodelling
may be due in large part to inﬂammation which may be infection related.7,8 The
supracervicallocation(i.e. close tothevaginal ﬂora)of thestructuralchangesobserved
in membranes prior and after rupture has supported the proposition that even in
term pregnancies infection is implicated. Microbial invasion of the amniotic cavity
is seen in 18% of term labours and 30% of term rupture of the membranes (ROM).9
However, pre-labour ROM (as distinct from labour with intact membranes) has a
greater association with infection.
Consequences of membrane rupture
In comparison to term ROM the rate of positive bacterial culture at the time of
PPROM in the absence of labour is approximately 25–40%.1 One–2% of pregnancies
with PPROM have clinical chorioamnionitis at presentation with 3–8% developing
subsequent chorioamnionitis.1 Maternal infection increases the risk of neonatal
infection9 and the risk of infection clinically detectable in either mother or baby
increases with duration of PPROM. A Nigerian study in 2007 of 356 women
attending a University hospital with PPROM <36 weeks (1994–2003) reported 20%
of patients delivered within 24 hours with 71% delivered between the 2nd and
10th day. The majority of women (29.7%) were 28–30 weeks gestation. All women
received prophylactic antibiotics and steroids if <34 weeks gestation. Twenty nine
per cent had evidence of chorioamnionitis of whom 70% had had multiple vaginal
examinations (a known risk factor for infection). Thirty eight per cent of those with
chorioamnionitis had received antibiotics within 24 hours of membrane rupture.
Those delivering within 48 hours were least likely to have chorioamnionitis.11 While
this study was at an institution within a developing nation with higher perinatal
morbidity and mortality than western studies the report demonstrates clearly the risk
of infection over time in the context of PPROM using current management strategies.
When considering management of PPROM risk of infection is thus the single most
important determinant of maternal and fetal morbidity and mortality and increases
with duration of ROM.
LATENCY IN PPROM
Pasquier et al12 reviewed all cases of PPROM at 24–33+6 weeks gestation (542 women)
attheirFrenchinstitutionbetweenApril1999–2001andreportedthat60%willdeliver
spontaneously during the ﬁrst week of PPROM, with 80% delivering within 3 weeks.
Cotton et al13 reported a latency of 3.6 ± 2 days (range 0.5–9 days) in 19 women
with PPROM with 52.6% delivering within 72 hours of admission. Manuck et al14
conﬁrmed that latency following PPROM at 22–33.9 weeks gestation was 8 days
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Predictive factors within the PPROM group to determine which cases have the
shortest latency have been reported. Fisher et al15 suggested that cervical length when
measured translabially is not predictive of latency, chorioamnionitis or postpartum
endometritis. However a Korean prospective study performed transabdominal
amniocentesis, sampled maternal blood for white cell count (WCC) and C reactive
protein (CRP) and measured cervical length in 50 singleton pregnancies < 36 weeks
with PPROM. Patients with positive amniotic ﬂuid cultures had signiﬁcantly shorter
cervical length and higher WCC and CRP than those with negative cultures. The
prevalence of positive culture was 26% (13/50) and the mean gestational age at
amniocentesis was 31.4 weeks. Using a ROC curve the best cut off value of cervical
length for identiﬁcation of microbial invasion of the amniotic cavity was 28 mm with
a sensitivity of 85% and a speciﬁcity of 65%.16 The latency from PPROM to delivery
is not reported but the authors cite several other studies with microbial invasion and
shorter latency from ROM to delivery in PPROM and infer that a short cervix would
therefore be associated with an earlier delivery. The quantity of remaining ﬂuid may
be predictive of latency. Parks et al17 studied 129 women with spontaneous PPROM
at < 35 weeks in whom 29% had an AFI < 5 cm. This level of ﬂuid was associated
with higher rates of positive ﬂuid cultures and a shorter PPROM to delivery interval.
Both cervical length and anhydramnios may be surrogate markers; of infection, with
infection being the main determinant of latency. A recent study by Manuck et al14
has suggested that latency per se is not a risk factor for adverse perinatal outcome but
congenital sepsis is (OR 13.2 95% CI 3.9–44.5).14 Thus with expectant management
the data suggest that a high proportion of women will deliver spontaneously within a
week but the risk of infection increases with duration of PPROM and it is the presence
of infection that is clinically important with respect to outcome.
ANTIBIOTICS IN PPROM
Antibiotic use has been shown to prolong pregnancy in the context of ROM.18
However, increasing gestation with antibiotics does not translate into long-term
beneﬁts for the offspring. The ORACLE I trial19 assessed the beneﬁt of erythromycin
and or amoxicillin/clavulinate and placebo for women with PPROM and no signs of
infection. While erythromycin was associated with prolongation of pregnancy and
reductions in neonatal morbidity, by the age of 7 years there was no difference in the
degree of functional impairment amongst children who received antibiotics compared
to those who did not.19
In the context of intact membranes and no signs of infection, antibiotics may
increase neonatal mortality when used in women in preterm labour.20 Most recently
this was reported in the second ORACLE 7 year follow up study. Women with pre-
term labour and intact membranes were randomised to the use of erythromycin
and/or amoxicillin/clavulinate or placebo. Eythromycin use was associated with an
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erythromycin. Either antibiotic was associated with more cerebral palsy than in
women receiving no antibiotics. The number needed to harm in the erythromycin
group was 64 (95% CI 37–209) and in the co-amoxiclav group 79 (42–591).21 These
studies highlight that in women at signiﬁcant risk of preterm birth use of antibiotics
has not been shown to have beneﬁt21 though they may prolong pregnancy. In the
context of PPROM therefore, measures to prolong pregnancy must be considered not
only in terms of increasing gestation but must translate into measurable long term
improvements in outcome for the neonate. Once evidence of clinical infection is
apparent delivery should be expedited and should be treated with antibiotics because
clinical chorioamnionitis remains an important cause of maternal, fetal and neonatal
death.19
ROLE OF AMNIOCENTESIS IN PPROM
Amniocentesis to detect fetal lung maturity
Given the delicate balance between risks of infection to mother and baby in PPROM
with expectant management and the beneﬁt of increasing gestation in the absence
of infection (particularly at early gestations), one role of amniocentesis in PPROM
would be to determine fetal lung maturity. If conﬁrmed, delivery could be expedited
rather than waiting for clinical infection to develop. In 1979, the previously cited
Garite study also used their amniotic ﬂuid samples, obtained by amniocentesis in 69
patients with PPROM at 28 to 35 weeks of gestation, to test for lung maturity using
the lecithin sphingomyelin LS ratio.22
Cotton et al13 studied 61 patients with PPROM at 27–36 week’s gestation. Liquor
was sampled transvaginally if seen to be pooling or by transabdominal amniocentesis.
Specimens were then sent for LS ratio and the presence of phosphatidyl glycerol,
gram stain and culture were also performed. Delivery was expedited if the LS ratio
was mature, or if bacteria were identiﬁed on gram stain. Antibiotics were only given
in cases of chorioamnionitis. Forty two amniocenteses were performed of which 7
also had vaginally acquired samples. Although the abdominal samples were of greater
volume, the results from the two sampling methods were not different. All patients
with bacteria on gram stain or culture subsequently developed chorioamnionitis.
Twenty six patients had a mature LS ratio (greater than or equal to 1.8). The mean
gestational age estimated by the obstetric team in these women was 32.3 ± 2 weeks.
Subsequent paediatric assessment suggested a mean gestational age of 33.2 ± 2.2
weeks. Three of 26 were believed to be 33 weeks by the obstetrician and 36 weeks
by the paediatrician. Where the LS ratio was mature, 23/26 women were delivered
within 48 hours and the remaining women were delivered by 96 hours. Four infants
delivered <32 weeks had a mature LS ratios and their neonatal stays were 23, 29, 46
and83days.Theauthorsconcludedthatatlessthan32weeksgestationamniocentesis
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this group, even in the presence of a mature LS ratio, that management should be
conservative. At 34 weeks neonatal morbidity is sufﬁciently reduced that delivery
should be considered. Thus between 32–34 weeks amniocentesis to assess fetal lung
maturity may have a role.13 Of note, in this study, corticosteroid administration for
fetal lung maturity was at the discretion of the attending physician. The discussion
explains that steroids were not given in sufﬁcient numbers to determine their efﬁcacy.
Whether the increased neonatal morbidity at <32 would have been reduced by routine
administration of steroids remains to be determined.
Several different methods have since been reported for assessing fetal lung
maturity eg TDx FLM II, phosphatidyl glycerol (PG) and lamellar body count (LBC).23
These methods are comprehensively reviewed by Grenache and Gronowksi.23 LS
ratio while still performed by many laboratories has a good sensitivity but lacks
speciﬁcity. Phosphatidyl glycerol is a late marker of fetal lung maturity. TDx FLM
II is a commercially available assay measuring the surfactant to albumin ratio by
ﬂuorescence polarization. The test is the most commonly used quantitative method
for determining fetal lung maturity and has good sensitivities (95.7–100%) with
speciﬁcities of 70–84%.23 Lamellar body count also functions well as a test of fetal
lung maturity with sensitivities approaching 100% and speciﬁcities 54–100%.23 The
authors conclude that while these tests perform well to determine maturity they are
poor predictors of immaturity and that given the increasing prevalence of respiratory
distress with reducing gestational age, risk stratiﬁed with regard to gestational age
might be a more useful tool.23 Thus in the context of PPROM a mature result
using a rapid test (TDx FLM II or LBC) is strongly predictive of the absence of RDS.
Inconclusive results may require additional testing.
Amniocentesis to identify bacterial infection
TheoverallrateofpositiveamnioticﬂuidcultureinpatientswithPPROMrangesfrom
25–40%.24 Averbach et al24 performed an amniocentesis in 90 consecutive patients
with PPROM at 23–36 weeks gestation for microbial culture, gram stain and white
cell count. Thirty six percent had positive cultures (e.g. ureaplasma urealyticum,
escherichia coli, proteus mirabilis and coagulase negative staphylococcus) but in
total 66% had evidence of infection (culture, gram stain and/or elevated WCC). The
clinical characteristics of the women were not different. The mean gestational age
at delivery in patients with intra-uterine infection was 31.0 ± 3.8 weeks, compared
to 33.0 ± 3.6 weeks in patients without intra-uterine infection. Birth weight and
Apgar score at 1 minute were signiﬁcantly lower in neonates born to mothers with
intra-uterine infection when compared to those without infection.24 In 1979, Garite
and colleagues22 obtained amniotic ﬂuid samples by amniocentesis in 69 patients
with PPROM at 28 to 35 weeks and tested lung maturity and screened for evidence
of intra-amniotic infection using gram stain, WCC, and culture for aerobic and
anaerobic bacteria.22 Nine cases had a positive amniotic ﬂuid culture, of which
seven developed clinically signiﬁcant amnionitis, a signiﬁcant neonatal infection,80 Anna P Kenyon et al.
post-partum endometritis or a combination of these.22 The other two patients
delivered within 24 hours. Of the 21 patients with negative amniotic ﬂuid culture
only one developed chorioamnionitis. This study provided preliminary evidence that
the presence of intra-amniotic infection deﬁnes a subgroup of patients at a higher risk
for perinatal complications.
Microorganisms can gain access to the uterine cavity ascending through the vagina
and cervix, by haematogenous dissemination through the placenta, by accidental
introduction at the time of invasive procedures or retrograde spread through the
fallopian tubes. Microorganisms are recognised by pattern recognition receptors
e.g. toll like receptors which release inﬂammatory cytokines and chemokines (e.g.
interleukin (IL) 8, IL-1beta and tumour necrosis factor alpha (TNF-). Microbial
endotoxins and proinﬂammatory cytokines stimulate prostaglandins (PG) other
inﬂammatory mediators and matrix degrading enzymes. Prostaglandins stimulate
uterine contractility whereas degradation of extracellular matrix in the fetal
membranes leads to PPROM.25 Infection then results in a fetal inﬂammatory response
syndrome (FIRS), which may or may not be associated with a maternal inﬂammatory
response. Once bacterial colonisation and maternal systemic response is established
fetal and maternal outcomes are much worse. Therefore to identify intramniotic
inﬂammation and/or infection prior to the onset of maternal symptoms of sepsis may
be beneﬁcial in terms of neonatal outcome.
Pathologic examination has been the gold standard for the diagnosis of
inﬂammation. However, chemotactic signals must be present for the white blood
cells to migrate to the site of injury or infection. Thus, there is a window of time
in which a “molecular signature of inﬂammation” is present before histological
evidence is observed.9 Thus inﬂammation is a spectrum and the absence of a
maternal fever, chills, rigors and leucocytosis does not exclude a bacterial insult
and inﬂammation.9 Romero et al26 have shown that exposure to intra-amniotic
inﬂammation and evidence of a systemic fetal inﬂammatory response (funisitis) are
strong and independent risk factors for the subsequent development of cerebral palsy.
It has therefore been suggested that amniocenteses following membrane rupture
may allow early identiﬁcation of colonisation of the amniotic cavity with bacteria
and fetal inﬂammation and thus provide a window prior to clinically detectable sepsis
or bacterial culture when intervention may be beneﬁcial.
Amniocentesis to detect novel markers of inﬂammation in the amniotic ﬂuid
Cytokines
In 1993, Romero and colleagues27 assessed the performance of amniotic ﬂuid gram
stain, WCC, the inﬂammatory cytokine IL-6, and glucose levels in detecting the
presence of microbial invasion of the amniotic cavity as deﬁned by a positive bacterial
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Figure 1. Tables reporting inﬂammation as measured by IL6 concentrations in amniotic ﬂuid and fetal cord
blood with respect to bacterial colonisation and neonatal morbidity (a) Classiﬁcation and procedure-to-
delivery interval of patients according to amniotic ﬂuid and fetal plasma IL-6 concentrations. (Reproduced
from Romero R, et al28 with permission.) (b) Severe neonatal morbidity according to presence of microbial
invasion of amniotic cavity and fetal plasma IL-6 concentration in 73 patients delivered within 7 days of
amniocentesis or cordocentesis. (Reproduced from Gomez R, et al29 with permission).
patients with preterm premature rupture of membranes was 38%. Amniotic ﬂuid
IL-6 levels were the most sensitive test (80.9%) for the detection of microbial invasion
of the amniotic cavity while the most speciﬁc test was the Gram stain of amniotic
ﬂuid (98.5%). When cultures were positive the amniocentesis-to-delivery interval was
shorter and the neonatal complication rate was higher. In 1998, the same group linked
amniotic ﬂuid inﬂammation to a fetal systemic inﬂammatory syndrome (FIRS). To do
this, they performed concurrent amniocentesis and cordocentesis in 30 patients with
PPROM at around 30 weeks of gestation.28 Microbial invasion of the amniotic cavity
was present in 58.5% of the patients. Fetuses with plasma IL-6 concentrations > 11
pg/mLhadasigniﬁcantlyhigherrateofspontaneouspretermdeliverywithin48and72
hours of the procedure than those with fetal plasma IL-6 levels < 11 pg/mL (Figure 1).82 Anna P Kenyon et al.
In addition, fetuses with plasma IL-6 concentrations > 11 pg/mL had a signiﬁcantly
higher rate of severe neonatal morbidity than did those with fetal plasma IL-6 levels
<11 pg/mL as evidenced in an accompanying study (Figure 1b).29
The data presented in Figure 1a suggests that most of the complications occur in
the subset of patients with evidence of an intra-amniotic infection/inﬂammation as
deﬁned by amniotic ﬂuid IL-6 level >7.9 ng/ml or a positive amniotic ﬂuid culture.
There remains a subset of patients with FIRS (fetal plasma IL-6> 11 pg/ml) where
amniotic ﬂuid cultures are negative and amniotic ﬂuid IL-6 levels are less than
7.9 ng/ml. This subset could represent early haematogenous infectious spread to
the fetus or a false-negative amniotic ﬂuid result. These fetuses remain at risk of
imminent delivery and poor neonatal outcome but cannot (according to the above
criteria) be identiﬁed without fetal blood sampling. For this reason, the authors, in
subsequent publications, suggest a lower threshold for the deﬁnition of intra-amniotic
inﬂammation. Using a threshold of 2.6 ng/ml for amniotic ﬂuid IL-6, intra-amniotic
inﬂammation was twice as common as intra-amniotic infection (deﬁned by a positive
culture) and could identify infection with a sensitivity of 90% and a speciﬁcity of
around 75–80%.30
Buhimschi et al31 have shown that proteomic mapping of the amniotic ﬂuid
reveals a proﬁle, designated as the Mass Restricted score that is highly characteristic
of intraamniotic inﬂammation. The authors have shown that the presence of four
protein biomarkers (neutrophil defensins-2 and -1 and calgranulins C and A) is highly
predictive of preterm birth, funisitis (a hallmark of fetal inﬂammatory syndrome) and
early neonatal sepsis. Of 158 women having amniocentesis to exclude infection in
the context of PPROM, histological chorioamnionitis was found in 64%. The Mass
Restricted score signiﬁcantly correlated with stages of histological chorioamnionitis
(r = 0.539, P<.001), grades of choriodeciduitis (r = 0.465, P<.001), and amnionitis (r =
0.536, P<.001). The authors concluded that proteomic analysis of amniotic ﬂuid may
provide an opportunity for early recognition of histological chorioamnionitis and may
in the future identify candidates for antenatal therapeutic interventions. Proteomic
mapping of markers is still a research tool but may represent a useful and sensitive
clinical adjunct in the future.31
Matrix Metalloproteinase Enzymes
As the matrix metalloproteinase (MMP) enzymes are involved in parturition,
premature rupture of the membranes, and intra-amniotic infection,32,34 these have
also been used to diagnose intra-amniotic inﬂammation in PPROM cases. Of the
various MMPs, MMP-8 has received most clinical attention. In a study assessing the
ability of amniotic ﬂuid MMP-8 to detect intra-amniotic infection and inﬂammation
as deﬁned by a positive amniotic ﬂuid culture and amniotic ﬂuid IL-6 levels greater
than 2.6 ng/ml, a positive amniotic ﬂuid MMP-8 test result (deﬁned as greater than
20 ng/ml) had a sensitivity of 90%, speciﬁcity of 80%, positive predictive value of
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Figure 2. Amniocentesis-to-delivery interval, according to the results of amniotic ﬂuid culture and amniotic
ﬂuid matrix metalloproteinase 8 (MMP-8) concentrations in 219 women with pre term premature rupture
of membranes. (Reproduced from Shim SS et al37 with permission).
infection.35 In this study, a positive MMP-8 was also an independent predictor of
interval to delivery and signiﬁcant neonatal morbidity.35
The major advantage of MMP-8 testing is that it is available as a bedside test (MMP-
8 PTD Check (SK Pharma, Kyunggi-do, Korea) requiring 20 ul of amniotic ﬂuid and 15
minutes to obtain results without the need for laboratory equipment.36 In contrast,
amniotic ﬂuid culture for microbiologic testing requires around 48 hours while the
IL-6 assay uses a commercially available enzyme-linked immunosorbent assay (R and
D systems, Minneapolis, USA) which, although much faster than culture, still needs
to be performed in a laboratory setting.
In a more recent study, Shim et al37 studied the clinical signiﬁcance of positive
amniotic ﬂuid MMP-8 (intra-amniotic inﬂammation) as compared to amniotic ﬂuid
culture (intra-amniotic infection). Patients with intra-amniotic inﬂammation or
infection had a shorter interval to delivery (ﬁgure 2) and more complications including
higher rates of preterm delivery, histologic chorioamnionitis, funisitis, low Apgar
scores and admission to neonatal intensive care unit as well as more signiﬁcant
neonatal morbidity and lower gestational age at birth and birth weight. These
complications were still statistically signiﬁcant after accounting for gestational age
at amniocentesis.3784 Anna P Kenyon et al.
There were no differences in the interval to delivery (Figure 2) or rate of
complications between patients with intra-amniotic inﬂammation and a negative
amniotic ﬂuid culture and patients with proven amniotic ﬂuid infection.37 These
dataindicatethatintra-amnioticinﬂammationisarisk-factorforadverseneonataland
maternal outcome as well as for impending preterm delivery irrespective of amniotic
ﬂuid culture results. The proportion of amniotic ﬂuid samples where inﬂammation
is observed in the absence of positive culture results could be partially explained by
the presence of atypical organisms such as Ureaplasma urealyticum since up to 40%
of these infections are missed using conventional cultures.38
The thresholds and criteria used for the deﬁnition of intra-amniotic inﬂammation
are variable despite most studies being performed by a limited number of associated
researchers. The task of interpreting the results and applying them clinically is
formidable.
Technique of amniocentesis in PPROM
Amniocentesis in PPROM should be done by an experienced operator. In many cases,
the reduced amount of amniotic ﬂuid means that access to a ﬂuid pocket is limited to
a narrow window. Garite et al22 suggested it might be only technically successful in
51% of the cases. A 22 gauge needle is most appropriate and the use of a small volume
syringe may help prevent blockage due to suction of the nearby the membranes. A
trans-amniotic approach is preferable but a trans-placental approach could be used
as long as the target pocket does not lie under the central portion of an anterior
placenta.39 In cases where no intra-amniotic infection or inﬂammation is evident at
amniotic ﬂuid analysis and the decision is made to continue with the pregnancy,
repeat amniocentesis in 1–2 weeks may be useful. This is justiﬁed by certain authors,
as there is evidence that in PPROM the incidence of intra-amniotic infection increases
with longer latency periods.40
Complications with late amniocentesis are rare. In 137 patients with PPROM
examined at 28–34 weeks of gestation, Yeast et al41 reported that amniocentesis was
successful in 66.4%. They could not attribute any maternal or neonatal morbidity to
the amniocentesis itself and the amniocentesis-delivery analysis suggested that the
amniocentesisdidnotacceleratedelivery.41 Thevolumeofﬂuidavailableforsampling
is a consideration. Cotton et al13 performed the procedure only in those with a pool
of at least 1×1c m . 13 Frequently only 1–2 ml of ﬂuid were sampled13 but this was
sufﬁcient for gram stain, culture and LS ratio. Of note Gramellini et al42 showed that
after genetic amniocentesis the amniotic ﬂuid index decreases by about 1 cm. The
amount of amniotic ﬂuid needed for inﬂammation/infection studies depends on the
studies being performed but in general just a few millilitres.Pre-term pre-labour rupture of membranes and the role if amniocentesis 85
Patient acceptability of amniocentesis in PPROM
There remains the issue of patient acceptability. It should be made clear to the parents
that there remains a lot of uncertainty especially regarding long-term outcomes.
Despite these difﬁculties, it is exciting to know that 70% of patients with PPROM
between 28 and 34 weeks would agree to participate in a randomized study comparing
expectant management with amniocentesis-based management.43 More importantly,
those who responded that they would not participate related their refusal to concerns
about the complications of amniocentesis such as fetal trauma, iatrogenic preterm
labour, infection or pain.
POTENTIAL ADJUNCTIVE THERAPIES IN PPROM: IMMUNOMODULATORS
In cases of intra-uterine inﬂammation or infection, the relatively mature fetus may
be best delivered. Conversely those fetuses below 32 weeks of gestation may be
candidates for in utero treatment. Intra-amniotic infection is rarely eradicated using
antibiotics.44 Antibiotics with adjunctive therapy might be best studied in those cases
wherethereisintra-amnioticinﬂammationintheabsenceofapositivecultureorgram
stain. Porecco et al39 retrospectively evaluated a policy of induction of labour where
intra-amniotic inﬂammation or infection was evident on amniocentesis, the group
managed according to amniocentesis results fared better than the conventionally
managed group in regard to composite neonatal morbidity with an average latency
period of around 1 week in both groups.39 However, the optimal timing of delivery in
the presence of intra-amniotic infection or inﬂammation is still unknown.
Since most of the damage in intra-uterine infection is caused by
inﬂammation mediated by cytokines45 a combination of antibiotic and anti-
inﬂammatory/immunomodulatory agents may prove to be effective in preventing
fetal injury and prolonging gestation. In a primate model of intra-uterine infection
using group B streptococci, the addition of indomethacin and dexamethasone to
the antibiotic regimen was effective in eradicating the infection, suppressing the
inﬂammatory response and prolonging gestation.46 In human neonatal sepsis, use
of steroids,47 intravenous immunoglobulins,48 and colony stimulating factors49 were
not effective in improving outcomes. Pentoxyphylline, which inhibits the production
of TNF-, was effective in reducing the levels of the pro-inﬂammatory cytokines
TNF- and IL-6 in premature infants with sepsis. Most importantly it reduced the
mortality rate in these infants by about 80%.50,51
CONCLUSION
There is a need for a randomised controlled trial of amniocentesis-guided management
(for the presence of bacteria and lung maturity) versus standard conservative
management of PPROM. Until this data is available there may be a role for86 Anna P Kenyon et al.
amniocentesis in PPROM at early gestations e.g. <32 weeks in selected cases
when the risk of delivery may outweigh the risks of remaining in utero. This is
particularly pertinent following the ORACLE trial when the beneﬁts of antibiotics
to prolong gestation has been called into question. However, antibiotics clearly have
an important role in those with clinical signs of infection and delivery should not
be delayed in these women. Detection of inﬂammation and potential therapies to
modify the inﬂammatory response are currently only in the research stage but in the
future may play a role in combination with amniocentesis to detect those pregnancies
which may be compromised. As we have learnt from the ORACLE studies,52 any trial
addressing outcome in pre-term birth must include robust long-term follow up of
infants. Perceived short-term beneﬁts in prolonging gestation may not translate to
long-term beneﬁt to children born as a result.
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